Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articles.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses.BMC research notes · 2012
   Trial
2. Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.JACC. Basic to translational science · 2023
   Article
3. Clinician Liability in Prescribing Antidepressants.Focus (American Psychiatric Publishing) · 2019
   Article
4. Fake Peer Review and Inappropriate Authorship Are Real Evils.Journal of Korean medical science · 2019
   Review
5. Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.Journal of general internal medicine · 2015
   Article
6. How basic scientists help the pharmaceutical industry market drugs.PLoS biology · 2013
   Article
7. Too few, too weak: conflict of interest policies at Canadian medical schools.PloS one · 2013
   Article
8. Ethics and Scientific Integrity in Public Health, Epidemiological and Clinical Research.Public health reviews · 2012
   Article
9. Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures.PLoS medicine · 2012
   Article
10. Challenging medical ghostwriting in US courts.PLoS medicine · 2012
    Article
11. Ghostwriting revisited: new perspectives but few solutions in sight.PLoS medicine · 2011
    Article

Corrections and comments

• Commented on by
  Challenging medical ghostwriting in US courts.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as